Ami Belmont, MD
Assistant ProfessorCards
About
Research
Publications
2026
Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety
Mitri E, Vogrin S, Peter J, Li P, Copaescu A, Day C, Goh M, Belmont A, Fernando S, Trubiano J, group I. Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety. Allergy 2026 PMID: 42285888, DOI: 10.1111/all.70411.Peer-Reviewed Original ResearchPeriprocedural Allergy Evaluation is Safe and Effective to Guide Subsequent Anesthesia Administration
Liao J, Belmont A, Su C, You L, Oh J, Son M, Kwah J. Periprocedural Allergy Evaluation is Safe and Effective to Guide Subsequent Anesthesia Administration. Journal Of Allergy And Clinical Immunology Global 2026, 100747. DOI: 10.1016/j.jacig.2026.100747.Peer-Reviewed Original ResearchRetrospective cohort studyAllergy evaluationHypersensitivity reactionsIndex reactionPerioperative anaphylaxisAllergy testingCohort study of adult patientsRetrospective cohort study of adult patientsPositive testStudy of adult patientsTertiary academic centerSkin test resultsComprehensive allergy evaluationTryptase levelsPatient demographicsAdult patientsPatient cohortNeuromuscular blocking agentsSkin testLocal anestheticsAcademic centersUS guidelinesPatientsAnesthesia administrationBlocking agentsLessons Learned: Approaches to Delabeling Penicillin Allergy Population-level care – effective vs. ineffective strategies for delabeling penicillin allergy.
Copaescu A, Belmont A, Fadugba O, Kraft M, Wolfson A. Lessons Learned: Approaches to Delabeling Penicillin Allergy Population-level care – effective vs. ineffective strategies for delabeling penicillin allergy. The Journal Of Allergy And Clinical Immunology In Practice 2026 PMID: 42106113, DOI: 10.1016/j.jaip.2026.04.023.Peer-Reviewed Original ResearchPenicillin allergy labelPatients' willingnessRoutine care pathwaysPatient-centered educationEquity-focused approachEvidence-based protocolsAllergy labelsPrimary careCare pathwaysUnderserved communitiesPractice toolkitPsychosocial challengesHealth systemSpecialist settingsDelivery modelsFlexible delivery modelsCommunication templateCultural beliefsClinical environmentPatient outcomesRisk stratification algorithmCareStakeholder engagementEquity considerationsAntimicrobial stewardshipEvaluating penicillin allergy clinical decision-making tools to enhance penicillin allergy delabeling
Su C, Belmont A, Son M, Liao J, Trubiano J, Kwah J. Evaluating penicillin allergy clinical decision-making tools to enhance penicillin allergy delabeling. Journal Of Allergy And Clinical Immunology Global 2026, 5: 100719. PMID: 42222591, PMCID: PMC13218126, DOI: 10.1016/j.jacig.2026.100719.Peer-Reviewed Original ResearchRetrospective chart reviewSkin test resultsPenicillin allergyFollow-up surveyClinical decision-making toolSkin testRetrospective chart review of patientsNegative skin test resultsChart review of patientsPositive skin test resultsAssociated with adverse outcomesReview of patientsLow-risk featuresNegative predictive valueNegative skin testsPenicillin allergy evaluationClinical decision ruleHealth care systemPenicillin allergy delabelingPenicillin challengePenicillin testingPenicillin useAllergy evaluationFollow-upAdverse outcomesValidity of PEN-FAST as a clinical decision tool in pregnant patients
You L, Belmont A, Liao J, Su C, Trubiano J, Son M, Burn M, Kwah J. Validity of PEN-FAST as a clinical decision tool in pregnant patients. Journal Of Allergy And Clinical Immunology Global 2026, 5: 100671. PMID: 41852857, PMCID: PMC12993893, DOI: 10.1016/j.jacig.2026.100671.Peer-Reviewed Original ResearchPregnant patientsPenicillin allergyOral challengeGestational ageSkin testLow riskPredictive valueNegative predicative valueNegative predictive valuePenicillin allergy testingAssociated with adverse patient outcomesSevere adverse eventsNegative likelihood ratioArea under the curvePositive predictive valueClinical decision toolClinical decision-making toolImmunology clinicRisk stratificationAdverse eventsAllergy evaluationAllergy testingAdverse patient outcomesPatientsPatient outcomes
2025
High-Risk Penicillin Reaction Flags in the Medical Record
Novotny S, Elmansy L, Kwah J, Liao J, Wong K, Stone C, Belmont A. High-Risk Penicillin Reaction Flags in the Medical Record. JAMA Network Open 2025, 8: e2549081. PMID: 41632130, PMCID: PMC12717615, DOI: 10.1001/jamanetworkopen.2025.49081.Peer-Reviewed Original ResearchOne Allergy, Two Paths: Navigating Penicillin Allergy Evaluation in Pregnant Patients, Direct Challenges Versus Penicillin Skin Testing in Pregnancy
Belmont A, Li L, Tsao L, Valente M, Wolfson A, Copaescu A. One Allergy, Two Paths: Navigating Penicillin Allergy Evaluation in Pregnant Patients, Direct Challenges Versus Penicillin Skin Testing in Pregnancy. The Journal Of Allergy And Clinical Immunology In Practice 2025, 14: 1261-1269.e1. PMID: 41319903, PMCID: PMC12690565, DOI: 10.1016/j.jaip.2025.11.030.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPenicillin skin testingSkin testPenicillin challengeGroup B streptococcal diseaseAmerican CollegeNeonatal adverse outcomesNon-pregnant patientsEvaluation of penicillin allergyStandard-of-care procedurePenicillin allergy labelShared decision-makingSensitive to penicillinRandomized clinical trialsStandard of careSevere allergic reactionsNeonatal morbidityPregnant patientsEvidence-based approachPenicillin allergyPenicillin administrationRisk-stratifiedAntibiotic useAllergy labelsOral challengeAdverse outcomesPrevalence and patient-level factors associated with common antibiotic allergy labels among patients undergoing hematopoietic stem cell transplants: a cross-sectional study
Belmont A, Reynolds J, Stone C, Dziura J, Malinis M, Phillips E, Sarpong D, Seropian S, Edelman E. Prevalence and patient-level factors associated with common antibiotic allergy labels among patients undergoing hematopoietic stem cell transplants: a cross-sectional study. The Journal Of Allergy And Clinical Immunology In Practice 2025, 14: 289-292.e2. PMID: 41161669, PMCID: PMC12753012, DOI: 10.1016/j.jaip.2025.10.016.Peer-Reviewed Original ResearchAnaphylaxis to Penicillin: Harvesting Insights From the Food and Drug Administration’s Adverse Event Reporting System
Belmont A, Novotny S, Mukherjee E, Park D, Wong K, Martin-Pozo M, Phillips E, Stone C. Anaphylaxis to Penicillin: Harvesting Insights From the Food and Drug Administration’s Adverse Event Reporting System. The Journal Of Allergy And Clinical Immunology In Practice 2025, 13: 3243-3253. PMID: 40752738, PMCID: PMC12926993, DOI: 10.1016/j.jaip.2025.07.039.Peer-Reviewed Original ResearchFood and Drug Administration Adverse Event Reporting SystemAnd Drug Administration Adverse Event Reporting SystemReports of anaphylaxisContemporary epidemiologyAdverse Event Reporting SystemReporting odds ratioPenicillin antibioticsCross-sectional studyEvent Reporting SystemReporting systemUnited StatesFAERS databaseHighest proportionSpecific PAOdds ratioAssociated with deathOddsPiperacillin-tazobactamMedicationAdverse eventsProportional reporting ratioAnaphylaxis reportsDisproportionality signalPharmacovigilance methodsAnaphylaxisAcquired angio-oedema as a mimicker of drug allergy
Liao J, Mathew M, Elmansy L, Hsu F, Belmont A. Acquired angio-oedema as a mimicker of drug allergy. BMJ Case Reports 2025, 18: e265525. PMID: 40389294, DOI: 10.1136/bcr-2025-265525.Peer-Reviewed Original ResearchConceptsAcquired angio-oedemaAngio-oedemaSplenic marginal zone lymphomaBradykinin-mediated diseaseSevere angio-oedemaMarginal zone lymphomaLocal anaesthetic allergyDrug allergy testingDental proceduresAcute therapyCase reportClinical historyDrug allergyAllergy centresAllergy testingClinical pearlsClinical diagnosisEmergency departmentMultiple physiciansDiagnosisAllergyLymphomaTherapyPatientsAetiology
Academic Achievements & Community Involvement
Clinical Care
Overview
Ami Belmont, MD, is a specialist in Rheumatology, Allergy, and Immunology, focusing on diagnosing and treating autoimmune conditions, allergic reactions, and immune system disorders. She helps patients manage conditions such as allergic rhinitis, asthma, and rheumatoid arthritis through a variety of treatments.
As an assistant professor at Yale School of Medicine, Dr. Belmont conducts research on penicillin allergy labeling, particularly among immunocompromised patients who have received stem cell transplants.
Dr. Belmont received her medical degree from the Warren Alpert Medical School of Brown University, and completed her residency in internal medicine and pediatrics, as well as her fellowship in rheumatology, allergy, and immunology, at Yale School of Medicine.
Clinical Specialties
Allergy & Clinical Immunology
Fact Sheets
Penicillin Allergy
Learn More on Yale Medicine
Board Certifications
Allergy & Immunology
- Certification Organization
- AB of Allergy & Immunology
- Original Certification Date
- 2023
Yale Medicine News
News
News
- February 03, 2026
Why Antibiotic Allergy Labels Deserve a Second Look
- October 23, 2024
Penicillin Allergies Among Patients Undergoing Hematopoietic Stem Cell Transplants
- December 14, 2023
Solving the Drug Allergy Puzzle: A Q&A With Ami Belmont
- October 23, 2023Source: Healio
Q&A: Patients With Verified Penicillin Allergies Safely Receive Cephalosporins
Get In Touch
Contacts
Appointment Number
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.